Cargando…

The Effects of Ramelteon on Glucose Metabolism and Sleep Quality in Type 2 Diabetic Patients With Insomnia: A Pilot Prospective Randomized Controlled Trial

BACKGROUND: Insomnia is associated with the onset and development of diabetes. Melatonin affects sleep quality and glucose metabolism in diabetic patients with insomnia. We administered ramelteon, an agonist of melatonin, to type 2 diabetic patients and investigated its effects on glucose metabolism...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsunoda, Tetsuji, Yamada, Masayo, Akiyama, Tomoaki, Minami, Taichi, Yoshii, Taishi, Kondo, Yoshinobu, Satoh, Shinobu, Terauchi, Yasuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087628/ https://www.ncbi.nlm.nih.gov/pubmed/27829954 http://dx.doi.org/10.14740/jocmr2754w

Ejemplares similares

The Effects of Bazedoxifene on Bone, Glucose, and Lipid Metabolism in Postmenopausal Women With Type 2 Diabetes: An Exploratory Pilot Study
por: Yoshii, Taishi, et al.
Publicado: (2015)

Predicting the ability of elderly diabetes patients to acquire the insulin self‐injection technique based on the number of animal names recalled
por: Minami, Taichi, et al.
Publicado: (2017)

Critical appraisal of ramelteon in the treatment of insomnia
por: Mets, Monique AJ, et al.
Publicado: (2010)

Pharmacotherapy of Insomnia with Ramelteon: Safety, Efficacy and Clinical Applications
por: Pandi-Perumal, Seithikurippu R., et al.
Publicado: (2011)

Defining criteria for the introduction of liraglutide using the glucagon stimulation test in patients with type 2 diabetes
por: Kondo, Yoshinobu, et al.
Publicado: (2013)

Therapeutic efficacy and anti-inflammatory effect of ramelteon in patients with insomnia associated with lower urinary tract symptoms
por: Shimizu, Nobutaka, et al.
Publicado: (2013)

A review of ramelteon in the treatment of sleep disorders
por: Neubauer, David N
Publicado: (2008)

The Melatonin Receptor Agonist Ramelteon Effectively Treats Insomnia and Behavioral Symptoms in Autistic Disorder
por: Kawabe, Kentaro, et al.
Publicado: (2014)

Use of Melatonin and/on Ramelteon for the Treatment of Insomnia in Older Adults: A Systematic Review and Meta-Analysis
por: Marupuru, Srujitha, et al.
Publicado: (2022)

Comparison of the effects of empagliflozin and glimepiride on endothelial function in patients with type 2 diabetes: A randomized controlled study
por: Tamura, Haruka, et al.
Publicado: (2022)

Ramelteon for Delayed Sleep-wake Phase Disorder: A Case Report
por: Takeshima, Masahiro, et al.
Publicado: (2020)

Predicting three categories of Dementia Assessment Sheet for Community‐based Integrated Care System 8‐items score‐based glycemic targets using the number of animal names recalled
por: Hiiragi, Hiroko, et al.
Publicado: (2023)

Ramelteon combined with an α(1)-blocker decreases nocturia in men with benign prostatic hyperplasia
por: Kawahara, Takashi, et al.
Publicado: (2013)

Effects of Add-on Ramelteon on Cognitive Impairment in Patients with Schizophrenia: An Open-label Pilot Trial
por: Shirayama, Yukihiko, et al.
Publicado: (2014)

Evaluation of the Anxiolytic Effect of Ramelteon in Various Rat Models of Anxiety
por: Nachiappan, KR, et al.
Publicado: (2023)

Actigraphy-based sleep and activity measurements in intensive care unit patients randomized to ramelteon or placebo for delirium prevention
por: Jaiswal, Stuti J., et al.
Publicado: (2023)

The optimal dose of Ramelteon for the better treatment adherence of delayed sleep–wake phase disorder: a dropout rate study
por: Takagi, Shunsuke, et al.
Publicado: (2023)

Melatonin and Its Agonist Ramelteon in Alzheimer's Disease: Possible Therapeutic Value
por: Srinivasan, Venkatramanujam, et al.
Publicado: (2010)

The Relief Effects of Ramelteon on Refractory Chronic Migraine: A Case Report
por: Hou, Yi-Cheng, et al.
Publicado: (2016)

Postoperative delirium after pharyngolaryngectomy with esophagectomy: a role for ramelteon and suvorexant
por: Booka, Eisuke, et al.
Publicado: (2017)

Ramelteon Reduces Oxidative Stress by Maintenance of Lipid Homeostasis in Porcine Oocytes
por: Sun, Jing-Tao, et al.
Publicado: (2022)

Correction to: A Randomized Controlled Trial of a Mini Low-Carbohydrate Diet and an Energy-Controlled Diet Among Japanese Patients With Type 2 Diabetes
por: Kimura, Masayo, et al.
Publicado: (2018)

A Randomized Controlled Trial of a Mini Low-Carbohydrate Diet and an Energy-Controlled Diet Among Japanese Patients With Type 2 Diabetes
por: Kimura, Masayo, et al.
Publicado: (2018)

Associations of impaired glucose tolerance and sleep disorders with mortality among the US general population
por: Inoue, Kosuke, et al.
Publicado: (2021)

Pharmacology of Ramelteon, a Selective MT(1)/MT(2) Receptor Agonist: A Novel Therapeutic Drug for Sleep Disorders
por: Miyamoto, Masaomi
Publicado: (2009)

Non‐24‐hour sleep‐wake disorder successfully treated with the combination of ramelteon and suvorexant in a case of autism spectrum disorder
por: Iwata, Masaaki, et al.
Publicado: (2020)

Association between ANGPTL3, 4, and 8 and lipid and glucose metabolism markers in patients with diabetes
por: Harada, Marina, et al.
Publicado: (2021)

On Sleep and Insomnia
Publicado: (1865)

Preventative effects of ramelteon against postoperative delirium after elective liver resection
por: Hokuto, Daisuke, et al.
Publicado: (2020)

Validity and reliability of the Japanese version of the diabetes knowledge test among in‐patients with type 2 diabetes
por: Minami, Taichi, et al.
Publicado: (2021)

Study on the preventive effect of ramelteon on the onset of sleep disorder after general anesthesia in patients with autism spectrum disorder: A study protocol
por: Ayuse, Terumi, et al.
Publicado: (2020)

Influence of Timing of Insulin Initiation on Long-term Glycemic Control in Japanese Patients with Type 2 Diabetes: A Retrospective Cohort Study
por: Miyazaki, Takashi, et al.
Publicado: (2019)

Comparison of Lipid-Lowering Effects of Anagliptin and Miglitol in Patients With Type 2 Diabetes: A Randomized Trial
por: Iijima, Takahiro, et al.
Publicado: (2020)

Melatonin receptor agonist ramelteon attenuates mouse acute and chronic ischemic brain injury
por: Wu, Xiao-li, et al.
Publicado: (2020)

Assessing the therapeutic potential of agomelatine, ramelteon, and melatonin against SARS-CoV-2
por: Yadalam, Pradeep Kumar, et al.
Publicado: (2022)

Sleep, Insomnia and Hypnotics
Publicado: (1892)

Metabolomics in Sleep, Insomnia and Sleep Apnea
por: Humer, Elke, et al.
Publicado: (2020)

Insomnia with objective short sleep duration is associated with longer duration of insomnia in the Freiburg Insomnia Cohort compared to insomnia with normal sleep duration, but not with hypertension
por: Johann, Anna F., et al.
Publicado: (2017)

Attenuation of Morphine Physical Dependence and Blood Levels of Cortisol by Central and Systemic Administration of Ramelteon in Rat
por: Motaghinejad, Majid, et al.
Publicado: (2015)

Agomelatine or ramelteon as treatment adjuncts in glioblastoma and other M1- or M2-expressing cancers
por: Kast, Richard E.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_9h4a29f6bg40klre866m7dmlmk